Stephen Hoge, President at Moderna, Inc. (MRNA), sold 78,369 shares at $213.47 ($17.0M) on 2026-10-14, disclosed to the SEC on 2026-10-16.
Scheduled sale ($17.0M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $213.47 | 38,774 | $8.3M | 48.6% |
| 2 | $214.15 | 450 | $96K | 0.6% |
| 3 | $220.72 | 39,145 | $8.6M | 50.8% |
| Total | $217.10 avg | 78,369 | $17.0M | 100% |
| Filing → |
| MRNA | SELL | 2026-06-17 | $2.7M | — | Filing → |
| MRNA | SELL | 2026-05-18 | $2.6M | — | Filing → |
| MRNA | SELL | 2026-02-25 | $7.8M | — | Filing → |